Follow
Vadim Tsvetnitsky
Vadim Tsvetnitsky
Director, Vaccine Development, IAVI
Verified email at iavi.org
Title
Cited by
Cited by
Year
Universal influenza vaccines: Shifting to better vaccines
FB Scorza, V Tsvetnitsky, JJ Donnelly
Vaccine 34 (26), 2926-2933, 2016
1722016
H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge
F Krammer, I Margine, R Hai, A Flood, A Hirsh, V Tsvetnitsky, D Chen, ...
Journal of virology 88 (4), 2340-2343, 2014
1242014
Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents
C Druar, F Yu, JL Barnes, RT Okinaka, N Chantratita, S Beg, CW Stratilo, ...
FEMS Immunology & Medical Microbiology 52 (1), 78-87, 2008
692008
Fatty acyl-CoA binding domain of the transcription factor FadR: characterization by deletion, affinity labeling, and isothermal titration calorimetry
CC DiRusso, V Tsvetnitsky, P Højrup, J Knudsen
Journal of Biological Chemistry 273 (50), 33652-33659, 1998
681998
Assessment of human immune responses to H7 avian influenza virus of pandemic potential: Results from a placebo–controlled, randomized double–blind phase I study of live …
L Rudenko, I Kiseleva, AN Naykhin, M Erofeeva, M Stukova, S Donina, ...
PloS one 9 (2), e87962, 2014
652014
Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study
L Rudenko, I Kiseleva, M Stukova, M Erofeeva, A Naykhin, S Donina, ...
Vaccine 33 (39), 5110-5117, 2015
332015
Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor
DL Lee, I Sharif, S Kodihalli, DIH Stewart, V Tsvetnitsky
Journal of Interferon & Cytokine Research 28 (2), 101-112, 2008
312008
Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus
I Isakova-Sivak, J de Jonge, T Smolonogina, A Rekstin, G van Amerongen, ...
PloS one 9 (7), e102339, 2014
302014
Live attenuated influenza vaccines against highly pathogenic H5N1 avian influenza: Development and preclinical characterization
N Larionova, I Kiseleva, I Isakova-Sivak, A Rekstin, I Dubrovina, ...
Vaccines Vaccination 4 (8), 208, 2013
242013
Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine
DM Carter, CE Bloom, GA Kirchenbaum, V Tsvetnitsky, I Isakova-Sivak, ...
Vaccine 33 (1), 108-116, 2015
212015
Purification and characterization of recombinant Streptomyces griseus aminopeptidase
SX Ni, D Cossar, A Man, K Norek, D Miller, C Kearse, V Tsvetnitsky
Protein expression and purification 30 (1), 62-68, 2003
162003
Characterization of phospholipid methylation in rat brain myelin
V Tsvetnitsky, L Auchi, A Nicolaou, WA Gibbons
Biochemical Journal 307 (1), 239-244, 1995
141995
S-adenosyl-l-homocysteine and 5′-methylthioadenosine inhibit binding of [3H] flunitrazepam to rat brain membranes
V Tsvetnitsky, IC Campbell, WA Gibbons
European journal of pharmacology 282 (1-3), 255-258, 1995
101995
PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries
KM Neuzil, V Tsvetnitsky, LJ Nyari, RA Bright, JW Boslego, ...
Expert review of vaccines 11 (8), 939-947, 2012
62012
Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam
HV Thang, VM Huong, JC Victor, CB Van, NT Nga, NP Cuong, ...
Vaccine 36 (46), 6918-6925, 2018
22018
The purification and molecular weight determination of rat liver microsomal phospholipid N-methyltransferase
WA Gibbons, L Auchi, K McBride, AN Fonteh, B Larijani, V Tsvetnitsky, ...
Biochemical Society Transactions 21 (4), 449S-449S, 1993
21993
Use of transient transfection for cGMP manufacturing of eOD-GT8 60mer, a self-assembling nanoparticle germline-targeting HIV-1 vaccine candidate
VK Sharma, V Tsvetnitsky, S Menis, ET Brower, E Sayeed, J Ackland, ...
bioRxiv, 2022.09. 30.510310, 2022
12022
Isozymes of rat brain myelin phospholipid-N-methyltransferase
V TSVETNITSKY, L AUCHI, FA YEBOAH, WA GIBBONS
Biochemical Society Transactions 21 (4), 489S-489S, 1993
11993
Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam.
HVT Ho Vinh Thang, VMH Vu Minh Huong, JC Victor, CBV Cao Bao Van, ...
2018
Current technologies for advancing HIV vaccines
V Tsvetnitsky
2016
The system can't perform the operation now. Try again later.
Articles 1–20